Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bayer Technology Services acquires microarray company.


Leverkusen, Germany 3/9/05--Bayer Technology Services GmbH (BTS BTS - Bug Tracking System ), a part of Bayer AG Bayer AG

German chemical and pharmaceutical company. Founded in 1863 by Friedrich Bayer (1825–1880), it now operates plants in more than 30 countries. Bayer has originated scores of pharmaceuticals, chemicals, and synthetic materials; it was the first developer and
, has acquired Zeptosens AG. Based in Witterswil, Switzerland, Zeptosens, a 1998 spin-off of Novartis, sells the ZeptoMARK protein microarrays, SensiChip DNA microarrays and SensiChip DNA microarray system based on fluorescence detection on the surface of a planar optical waveguide waveguide, device that controls the propagation of an electromagnetic wave so that the wave is forced to follow a path defined by the physical structure of the guide. . "The know-how and intellectual property of Zeptosens are an excellent complement to BTS's existing technology portfolio for planar waveguides and biochip biochip

Small-scale device, analogous to an integrated circuit, constructed of or used to analyze organic molecules associated with living organisms. One type of theoretical biochip is a small device constructed of large organic molecules, such as proteins, and capable of
 technologies," said Dr. Helmut Mothes, senior vice president of BTS Process Technology.
COPYRIGHT 2005 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:News, Trends & Market Intelligence for Instrument Executives
Comment:Bayer Technology Services acquires microarray company.(News, Trends & Market Intelligence for Instrument Executives)
Publication:Instrument Business Outlook
Geographic Code:4EXSI
Date:Mar 31, 2005
Words:86
Previous Article:Biotage adds process instrument business to argonaut purchase.
Next Article:Three laboratory product companies restate financials.
Topics:



Related Articles
Executive Briefing.
Executive Briefing.
2001: The year of the microarray?
LION GETS NEW AND UPGRADED LICENSES FOR SRS.
Instrumentation M&A activity reaches new heights.
Bioinstrumentation market comes down to earth.
Waters revised earnings roil instrument industry.
Affymetrix and Agilent pursue new microarray markets.
PerkinElmer acquires microarray company spectral genomics.
Roche acquires NimbleGen, building microarray business.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles